Goldman Sachs Alternatives
VC Fund
Goldman Sachs Alternatives is a VC fund focused on Software and Biotechnology. Goldman Sachs Alternatives specializes in investment strategies that encompass private equity, private credit, real estate, and infrastructure. The firm leverages its extensive network and expertise to identify and manage alternative asset opportunities. By integrating sustainability and inclusion into its investment approach, Goldman Sachs aims togenerate positive impacts alongside financial returns.
- Total investments:
- 75
- Last investment:
- Lead investor:
- 69%
Last updated:
For AI agents: llms.txt
Industries Goldman Sachs Alternatives invests in
Stages Goldman Sachs Alternatives invests in
Countries Goldman Sachs Alternatives invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ben Fife
|
|||
Gabriel Mollerberg
|
|||
Teresa Mattamouros
|
|||
Investment Focus
Industry
- Software 7 (9%)
- Biotechnology 6 (8%)
- Health Care 5 (7%)
- SaaS 4 (5%)
- Medical 4 (5%)
Stage
- Series B 8 (11%)
- Series C 6 (8%)
- Private Equity 5 (7%)
- Series A 3 (4%)
- Series D 3 (4%)
Country
- United States 20 (27%)
- United Kingdom 2 (3%)
- Canada 1 (1%)
- France 1 (1%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ben Fife
Vice President - GS Growth
|
Vice President - GS Growth | Total investments: 1 | Find email | |
|
Gabriel Mollerberg
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Teresa Mattamouros
Managing Director, Asset & Wealth Management (Infrastructure Fund)
|
Managing Director, Asset & Wealth Management (Infrastructure Fund) | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Harvey
|
Harvey is an artificial intelligence technology service provider. | Private Equity / Jul 28, 2026 | |
Paradigm Oral Surgery
|
Paradigm Oral Health is the preeminent provider of oral surgery. The capacity of Paradigm to hire the most elite oral surgeons in the country and train them on their exclusive platform of excellence distinguishes them. Through continual technological and digital workflow developments, Paradigm Oral Health continues to modernise and reinvent implantsurgery. Paradigm welcomes every opportunity to address the requirements of their patients and referring dentists with a passion for excellence. | Private Equity / Jul 23, 2026 | |
Spectro Cloud
|
Spectro Cloud is an enterprise software company that develops an AI infrastructure and cloud-native infrastructure management platform for enterprises and public sector organizations. It helps organizations deploy, manage, govern, and scale Kubernetes, virtual machines, edge computing, and AI infrastructure across public cloud, private cloud, baremetal, and edge environments through a unified control plane.The company's flagship platforms, Palette and PaletteAI, provide Kubernetes lifecycle management, AI infrastructure orchestration, GPU resource management, virtual machine modernization, edge computing management, policy-based governance, security, and infrastructure automation. The platforms enable organizations to provision and manage infrastructure from operating systems to applications and AI models, automate cluster operations, enforce security and compliance policies, optimize GPU utilization, and operate distributed environments, including air-gapped and sovereign deployments, at enterprise scale. | $100M / Series D / Jul 15, 2026 | |
Taktile
|
Taktile develops an AI-based decision platform for financial institutions to manage risk-related processes across the customer lifecycle. Its platform enables teams to design, test, deploy, and optimize decision strategies for customer onboarding, credit underwriting, fraud detection, anti-money laundering investigations, and transactionmonitoring. Taktile combines automated workflows, configurable business rules, third-party data integrations, and human review capabilities to support decision-making in regulated environments. The platform also provides tools for experimentation, performance monitoring, and case management, allowing organizations to evaluate and refine their decision processes over time. Taktile serves banks, insurers, and financial technology companies seeking to automate and govern operational and risk decisions. | $110M / Series C / Jun 24, 2026 | |
|
Taktile
|
Taktile develops an AI-based decision platform for financial institutions to manage risk-related processes across the customer lifecycle. Its platform enables teams to design, test, deploy, and optimize decision strategies for customer onboarding, credit underwriting, fraud detection, anti-money laundering investigations, and transactionmonitoring. Taktile combines automated workflows, configurable business rules, third-party data integrations, and human review capabilities to support decision-making in regulated environments. The platform also provides tools for experimentation, performance monitoring, and case management, allowing organizations to evaluate and refine their decision processes over time. Taktile serves banks, insurers, and financial technology companies seeking to automate and govern operational and risk decisions. | $110M / Series C / Jun 24, 2026 | |
Float Financial
|
Float offers modern financial services, powerful software and industry-leading support designed for every company and stage of growth. Our product suite includes corporate cards, bill pay, expense management and high-yield accounts, giving finance teams everything they need to manage spending and cash flow efficiently. | $59.7M / Series C / Jun 24, 2026 | |
AlphaSense
|
AlphaSense is a market intelligence platform that allows professionals to make critical decisions with confidence and speed. The company has nearly 2,000 enterprise clients, including financial institutions that use the platform to inform their business decisions. AlphaSense is trusted by over 1,800 enterprise customers, including a majority of theS&P 500. | $350M / Venture - Series Unknown / Jun 03, 2026 | |
Scutum Group
|
Scutum Group is a security company offering fire protection, cybersecurity, surveillance, and risk management solutions systems. AI | Private Equity / May 01, 2026 | |
Aidoc
|
Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel. | $150M / Series E / Apr 29, 2026 | |
Kashable
|
Kashable offers low-cost loans for any purpose. Eligible federal and company-sponsored employees can apply online in minutes and set up automatic repayment via structured payroll deductions.Kashable is an intelligent option for those looking to tackle expensive debt, cover unexpected expenses, or access an affordable financing option. We providean instant decision online with funds deposited directly to your bank account within 3 business days from approval. We are Socially Responsible Credit™ | $60M / Series C / Apr 27, 2026 | |
| See all 75 investments → | |||
Co-Investors
IVP
4 deals together
T. Rowe Price
4 deals together
Y Combinator
4 deals together
Apollo
3 deals together
Atlassian Ventures
3 deals together
D. E. Shaw & Co.
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Goldman Sachs Alternatives invest in?
Goldman Sachs Alternatives invests primarily in Software, Biotechnology and Health Care startups, most often at Series B and Series C stage. Most of the 75 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Goldman Sachs Alternatives?
Public channels for Goldman Sachs Alternatives include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Goldman Sachs Alternatives?
The team at Goldman Sachs Alternatives includes Ben Fife (Vice President - GS Growth), Gabriel Mollerberg (Managing Director) and Teresa Mattamouros (Managing Director, Asset & Wealth Management (Infrastructure Fund)). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
